Target intelligence / Profile preview

Bacterial intracellular macromolecules

Molecular classification
Enzyme, Nucleic acid, Ribosome, Protein, Other
01

Overview

Bacterial intracellular macromolecules represent a broad category of essential biological polymers and complexes found within the bacterial cell, including genomic DNA, various RNA species, ribosomes, and metabolic enzymes (Kapoor et al., 2017; Lambert, 2002). These components are vital for the maintenance of life, facilitating the storage and replication of genetic information, the transcription of genes, and the translation of proteins necessary for cellular structure and function (Wilson, 2014). In clinical medicine, these macromolecules serve as the primary targets for most classes of antibiotics; for instance, fluoroquinolones target DNA-processing enzymes, while macrolides and aminoglycosides bind to ribosomal subunits to halt protein synthesis (Kohanski et al., 2010). Because many of these intracellular processes are distinct from those in human cells, they allow for selective toxicity, although the high degree of conservation between bacterial machinery and human mitochondrial components can lead to adverse side effects (Wilson, 2014). The study of these targets is central to overcoming antibiotic resistance, as bacteria often evolve mechanisms to modify these macromolecules or bypass the inhibited pathways (Blair et al., 2015).

Other names
Bacterial cytoplasmic macromoleculesBacterial nucleic acids and proteinsIntracellular bacterial componentsBacterial cytoplasmic targets
02

Mechanism of action

Inhibition of DNA gyrase and topoisomerase IV, inhibition of DNA-dependent RNA polymerase, inhibition of the 30S or 50S ribosomal subunits, and inhibition of essential metabolic enzymes such as dihydrofolate reductase.

03

Biological functions

DNA replicationTranscriptionTranslationMetabolic catalysisGenetic inheritance
04

Disease associations

Infection
05

Safety considerations

Development of antimicrobial resistance (AMR)Mitochondrial toxicity due to structural homology with bacterial machineryDisruption of the human commensal microbiomeHypersensitivity and off-target host toxicity
06

Interacting drugs

Ciprofloxacin

5 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial DNA/RNA loadProcalcitoninC-reactive protein (CRP)

Beyond the preview

Go deeper on Bacterial intracellular macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial intracellular macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call